Fig. 2: Genomic alterations in mUC.
From: The genomic and transcriptomic landscape of metastastic urothelial cancer
A Driver gene mutations in mUC. Clinical features, immunohistochemical subgroups, and somatic genetic alterations identified in 97 mUC subjected to whole-exome sequencing. The effects of the somatic alterations are color-coded according to the legend. B Main altered pathways in mUC. Frequently altered genes were regrouped into specific signaling pathways detailed in Supplementary Table 4. Clinical features, immunohistochemical subgroups, and somatic genetic alterations identified in 97 mUC subjected to whole-exome sequencing. ICI Immune Checkpoint Inhibitor. Differential analysis between groups was performed using Fisher’s exact test, and Benjamini–Hochberg correction, two-sided. Source data are provided as a Source Data file.
